JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deacon, A C
Right arrow Articles by Elder, G H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deacon, A C
Right arrow Articles by Elder, G H
J Clin Pathol 2001; 54:500-507
© 2001 Journal of Clinical Pathology


Leader

ACP Best Practice No 165

Front line tests for the investigation of suspected porphyria

A C Deacon1, G H Elder2

Department of Clinical Biochemistry, King's College Hospital, Denmark Hill, London SE5 9RS, UK
Department of Medical Biochemistry, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XN, UK

Professor Elder elder{at}cardiff.ac.uk The porphyrias are uncommon disorders of haem biosynthesis and their effective management requires prompt and accurate diagnosis. This article describes methods for the determination of urinary porphobilinogen, urinary and faecal total porphyrins, and total porphyrins in erythrocytes and plasma that are suitable for use in non-specialist laboratories. The selection and interpretation of these methods, and the indications for further, more specialised, investigation are discussed.

Key Words: porphyria • haem biosynthesis • best practice guidelines




This article has been cited by other articles:


Home page
Arch DermatolHome page
C. Herrero, J. To-Figueras, C. Badenas, M. Mendez, P. Serrano, R. Enriquez-Salamanca, and M. Lecha
Clinical, Biochemical, and Genetic Study of 11 Patients With Erythropoietic Protoporphyria Including One With Homozygous Disease
Arch Dermatol, September 1, 2007; 143(9): 1125 - 1129.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. G. Goodwin, W. J. Kell, P. Laidler, C. C. Long, S. D. Whatley, M. McKinley, M. N. Badminton, A. K. Burnett, G. T. Williams, and G. H. Elder
Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells
Blood, January 1, 2006; 107(1): 60 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
S D Whatley, N G Mason, M Khan, M Zamiri, M N Badminton, W N Missaoui, T A Dailey, H A Dailey, W S Douglas, N J Wainwright, et al.
Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease
J. Med. Genet., August 1, 2004; 41(8): e105 - e105.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
S. Sandberg and G. H. Elder
Diagnosing Acute Porphyrias
Clin. Chem., May 1, 2004; 50(5): 803 - 805.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
P J van Diest, H Holzel, M Reid, M Crook, and G Spickett
Electronic publishing and internet learning
J. Clin. Pathol., December 1, 2002; 55(12): 881 - 882.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.